Jun Chen

Jun Chen

Auto-generated profile, based on publicly available information

Jun Chen

Bayer Healthcare, Wuhan 430000, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2020 in ACS Synthetic Biology
Verified
Journal Article
Open access
Xiaobo LiXiaobo Li
Xiaobo Li
JCJun Chen
Jun Chen
JAJoakim Mark Andersen
Joakim Mark Andersen
JCJu Chu
Ju Chu
PJPeter Ruhdal Jensen
Peter Ruhdal Jensen
Saccharopolyspora erythraea is used for industrial erythromycin production. To explore the physiological role of intracellular energy state in metabolic regulation by S. erythraea, we initially overexpressed the F1 part of the endogenous F1F0-ATPase in the high yielding erythromycin producing strain E3. The F1-ATPase expression resulted in lower [ATP]/[ADP] ratios, which was accompanied by a strong increase in the production of a reddish pigment and a decreased erythromycin production. Subsequent transcriptional analysis revealed that the lower intracellular [ATP]/[ADP] ratios exerted a pleotropic regulation on the metabolism of S.erythraea. The lower [ATP]/[ADP] ratios induced physiological changes to restore the energy balance, mainly via pathways that tend to produce ATP or regenerate NADH. The F1-ATPase overexpression strain exhibited a state of redox stress, which was correlated to an alteration of electron transport at the branch of the terminal oxidases and S. erythraea channeled the enhanced glycolytic flux towards a reddish pigment in order to reduce NADH formation. The production of erythromycin was decreased which is in accordance with the net ATP requirement and the excess NADH formed through this pathway. Partial growth inhibition by apramycin increased the intracellular [ATP]/[ADP] ratios, and demonstrated a positive correlation between [ATP]/[ADP] ratios and erythromycin synthesis. Finally, overexpression of the entire F1F0-ATPase complex resulted in 28% enhanced erythromycin production and markedly reduced pigment synthesis in E3. The work illustrates a feasible strategy to optimize the distribution of fluxes in secondary metabolism.

4 February 2022 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
JLJi Li
Ji Li
ZLZhanju Liu
Zhanju Liu
PHPinjin Hu
Pinjin Hu
ZWZhonghui Wen
Zhonghui Wen
QCQian Cao
Qian Cao
JQJiaming Qian
Jiaming Qian
Background: Prevalence of inflammatory bowel disease (IBD) is increasing in China. The EXPLORE study evaluated the incidence and indicators of suboptimal responses to first-line anti-tumor necrosis factor (TNF) in patients with ulcerative colitis (UC) or Crohn’s disease (CD). We present results for the mainland China subgroup. Methods: A retrospective chart review was performed in adults with IBD at 10 centers in mainland China who initiated anti-TNF therapy between 01 March 2010 and 01 March 2015. The cumulative incidence of suboptimal response to first-line anti-TNF therapy was assessed over 24 months using the Kaplan–Meier method. Indicators of suboptimal response were: dose escalation, discontinuation, augmentation with non-biologic therapy, or IBD-related surgery/hospitalization. At site initiation, a survey was conducted with participating physicians to identify barriers to anti-TNF use. Results: Of 287 patients (72% male) examined, 16/35 (45.7%) with UC and 123/252 (48.8%) with CD experienced a suboptimal response to first-line anti-TNF therapy at any point during the observation period (median 27.6 and 40.0 months, respectively). At 1 and 2 years post anti-TNF initiation, the cumulative incidence of suboptimal response was 51.4% and 75.7% for UC and 45.4% and 57.0% for CD, respectively. Median time to first suboptimal response was 7.2 months for UC and 14.3 months for CD. The most frequent indicator of suboptimal response was discontinuation of anti-TNF therapy (9/16, 56.3%) for UC and IBD-related hospitalization for CD (69/123, 56.1%) followed by augmentation with non-biologic therapy for both cohorts (5/16, 31.3% for UC and 28/123, 22.8% for CD). Dose escalation was the least frequent indicator of suboptimal response to anti-TNF therapy (CD: 4/123, 3.3%; UC: not cited as an indicator). The cumulative incidence of suboptimal response within 4 months of first-line anti-TNF therapy (primary non-response) was over 30% in both cohorts. Financial reasons and reimbursement were identified by surveyed physicians as the most common barriers to prescribing an anti-TNF therapy. Conclusions: Over one-half of patients with IBD are at risk of experiencing a suboptimal response to first-line anti-TNF therapy at 2 years post-initiation in China. This study highlights a substantial unmet need associated with anti-TNF therapies in China. (Clinicaltrials.gov identifier: NCT03090139).

1 May 2014 in Neuroscience
Verified
Journal Article
Closed access
WJWei Jiang
Wei Jiang
LCL. Chen
L. Chen
XZX.J. Zhang
X.J. Zhang
JCJ. Chen
J. Chen
XLX.C. Li
X.C. Li
NXN. Xiao
N. Xiao

1 December 2007 in Chinese Medical Journal
Verified
Journal Article
Open access
JCJun Chen
Jun Chen
XXXiao Xu
Xiao Xu
QLQi Ling
Qi Ling
JWJian Wu
Jian Wu
SZShusen Zheng
Shusen Zheng
Pittsburgh modified TNM criteria is one of the prognostic models of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). In this study, we applied this prognostic system in a series of HCC patients receiving OLT to verify its reliability in the clinical prognostic prediction. The clinical record and follow-up data of 102 patients with HCC underwent OLT was collected. The patients were classified by 3 staging systems: the Pittsburgh Modified TNM Criteria, International Union Against Cancer (UICC) pTNM Staging System, and Milan Criteria. Survival rates of the patients were analyzed using the Kaplan-Meier method and the Log-Rank test, and then the prognostic values of the 3 staging systems were compared. Among the 3 staging systems, the Pittsburgh Modified TNM Criteria showed the best stratification of patients with different prognosis. The overall survival rates of the patients at the Pittsburgh modified TNM stage I, II, III, and IV were 94.4%, 83.3%, 58.2%, and 36.8% at 1 year, and 79.4%, 62.5%, 26.2%, and 10.5% at 3 years, respectively. For those patients exceeding the Milan Criteria, the patients at Pittsburgh stages I and II had a significant higher survival rate than those at Pittsburgh stages III and IV (P<0.001). The Pittsburgh Modified TNM Criteria is a more reliable postoperative staging system than the UICC pTNM staging system for HCC patients receiving OLT. As providing more accurate prognostic classification, it could be reasonable to combine the Milan Criteria for recipient selection.

13 December 2020
Verified
Conference Paper
Closed access
JCJun Chen
Jun Chen
YZYue Zhang
Yue Zhang
XGXudong Gao
Xudong Gao
The learning algorithm of fuzzy cognitive map(FCM) is mainly based on expert intervention or effective historical data to learn the weight value in weight matrix W. With the increase of the number of nodes, the number of weights need to be learned will also increase square, the performance of the learning algorithm will decline sharply. Therefore, it is an important task to design a high-performance learning algorithm which depends on expert knowledge as little as possible. A single learning algorithm has some limitations, such as easy local optimization, slow learning rate and so on. Among them, particle swarm optimization algorithm has strong global optimization ability, which can quickly optimize the weight matrix to a certain accuracy, but the follow-up optimization time is too long. For the gradient descent algorithm, when the initial value is chosen properly, its can approach the global optimal solution quickly. In this paper, we design particle swarm optimization (PSO) and gradient descent algorithm (GDA) to learn FCM respectively. According to the characteristics of the two algorithms, a hybrid algorithm(HA) is proposed: first, the PSO algorithm is used to optimize weight matrix to a certain accuracy, then the gradient descent method is added, which makes up for the disadvantage that the error of single PSO algorithm decreases slowly in the later stage. Experimental results show that the hybrid algorithm proposed in this paper has a significant improvement in both accuracy and speed.

28 June 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
GYGuanjie Yuan
Guanjie Yuan
LCLingli Cai
Lingli Cai
WQWeinuo Qu
Weinuo Qu
ZZZiling Zhou
Ziling Zhou
PLPing Liang
Ping Liang
ZLZhen Li
Zhen Li
Urgent detection of calculous pyonephrosis is crucial for surgical planning and preventing severe outcomes. This study aims to evaluate the performance of computed tomography (CT)-based radiomics and a three-dimensional convolutional neural network (3D-CNN) model, integrated with independent clinical factors, to identify patients with calculous pyonephrosis. We recruited 182 patients receiving either percutaneous nephrostomy tube placement or percutaneous nephrolithotomy for calculous hydronephrosis or pyonephrosis. The regions of interest were manually delineated on plain CT images and the CT attenuation value (HU) was measured. Radiomics analysis was performed using least absolute shrinkage and selection operator (LASSO). A 3D-CNN model was also developed. The better-performing machine-learning model was combined with independent clinical factors to build a comprehensive clinical machine-learning model. The performance of these models was assessed using receiver operating characteristic analysis and decision curve analysis. Fever, blood neutrophils, and urine leukocytes were independent risk factors for pyonephrosis. The radiomics model showed higher area under the curve (AUC) than the 3D-CNN model and HU (0.876 vs. 0.599, 0.578; p = 0.003, 0.002) in the testing cohort. The clinical machine-learning model surpassed the clinical model in both the training (0.975 vs. 0.904, p = 0.019) and testing (0.967 vs. 0.889, p = 0.045) cohorts.